pocketful logo light
pocketful logo light
Senores Pharmaceuticals Ltd logo

Senores Pharmaceuticals Ltd

NSE: SENORES BSE: 544319

₹1290

(11.14%)

Wed, 24 Jun 2026, 01:18 am

Senores Pharmaceuticals Share Price Live Chart

1 Day

(11.14%)

No Result Found

Summary

  • Market Cap (in Cr)

    5148.56

  • Net Profit (in Cr)

    58.34

  • P/B

    3.35

  • Sector P/E

    33.76

  • P/E

    45.03

  • EV/EBITDA

    23.56

  • Debt/Equity (Industry)

    0.26

  • Interest Cover (Industry)

    10.81

  • ROCE (Industry)

    16.40

  • RONW (Industry)

    14.39

  • ROE

    11.78

  • ROCE

    11.75

  • Debt/Equity

    0.58

  • EPS (TTM)

    25.05

  • Dividend Yield

    0

  • Book Value

    202.72

  • Interest Cover

    4.27

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters45.8245.8045.8045.7845.77
FII3.643.354.283.664.17
DII9.619.318.619.519.65
Public40.9341.5441.3141.0540.40
Government00000

Read More

Technical Analysis

RSI

67.85

MACD

79.80

50 DMA

1036.83

200 DMA

837.67

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic1697.901381.051250.851064.20934747.35430.50
Fibonacci1381.051260.011185.241064.20943.16868.39747.35
Camarilla1207.781178.741149.691064.201091.611062.561033.52

Pivots Level: Classic

R3

+633.70

1697.90

R2

+316.85

1381.05

R1

+186.65

1250.85

1064.20
1064.20
Pivot Point
LTP: 1286.60

S1

-130.20

934

S2

-316.85

747.35

S3

-633.70

430.50

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    1250.40

  • 20-EMA

    1187.12

  • 30-EMA

    1137.94

  • 50-EMA

    1065.19

  • 100-EMA

    962.88

  • 200-EMA

    855.52

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
14 May 2026board-meetingsAccounts
20 Jan 2026board-meetingsQuarterly Results
07 Jan 2026egm
06 Nov 2025board-meetingsQuarterly Results
26 Aug 2025agm

Read More

Peer Comparison

Senores Pharmaceuticals Ltd logo

Senores Pharmaceuticals Ltd

Cipla Ltd logo

Cipla Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Read More

Senores Pharmaceuticals Ltd About

Senores Pharmaceuticals is engaged in the business of manufacturing, marketing and trading of pharmaceuticals and allied products and also providing management and consultancy services.

Industry

Pharmaceuticals - Indian - Formulations

Founded

2017

Headquarters

CEO

Sanjay Majmudar

Employees

Contact

Website icon

Website

http://www.senorespharma.com

Email icon

Email

cs@senorespharma.com

Phone icon

Phone

+91-79-2999 9857

Location icon

Location

#.1101-1103 11th Flr South Twr, Ambali Bopal Road, Ahmedabad, Gujarat, 380054

Read More

Senores Pharmaceuticals Ltd Company History

YearHistory
2017
  • The company was originally incorporated as Senores Pharmaceuticals Private Limited.
2021
  • Incorporated a wholly owned subsidiary, Senores Pharmaceuticals Inc, in the US.
  • Entered into a new segment of API with the acquisition of Ratnagene Lifescience Private Limited.
2022
  • Started the domestic business with the launch of critical care injectables.
2023
  • Changed the company name to Senores Pharmaceuticals Limited upon conversion to a public limited company.
  • Received approval from the central government for the name change.
  • Obtained a fresh certificate of incorporation reflecting the name change.
2024
  • Launched first CMO product in the US with Jubilant Cadista.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
ASTORNE CAPITAL VCC ARVENbulkSell500000792.1224 Dec 2025
YASHKUMAR SHANTILAL SANGHVIbulkSell27627079224 Dec 2025
RAVI PAWANKUMAR SANGHVIbulkSell292500792.1924 Dec 2025
GRAVITON RESEARCH CAPITAL LLPbulkSell316091689.9829 Jul 2025
HRTI PRIVATE LIMITEDbulkBuy269264686.6629 Jul 2025
GRAVITON RESEARCH CAPITAL LLPbulkBuy316091689.3329 Jul 2025
HRTI PRIVATE LIMITEDbulkSell237321688.8729 Jul 2025
QE SECURITIES LLPbulkBuy244396686.0124 Jul 2025
GRAVITON RESEARCH CAPITAL LLPbulkBuy639285684.9624 Jul 2025
GRAVITON RESEARCH CAPITAL LLPbulkSell639285685.4424 Jul 2025

Read More

Senores Pharmaceuticals Ltd News

Senores Pharmaceuticals relieves Company Secretary

Senores Pharmaceuticals relieved Company Secretary Vinay Kumar Mishra from duties effective June 10, 2026. Managing Director Swapnil Jatinbhai Shah and CFO Deval Rajnikant Shah are now authorized for disclosures.

10 Jun 2026

companies

Senores Pharma investor meet on June 12

Senores Pharmaceuticals will hold a virtual investor conference on June 12, 2026, hosted by Choice Broking. Discussions will rely on publicly available information.

09 Jun 2026

companies

Senores Pharmaceuticals to host investor meet

Senores Pharmaceuticals will hold an analyst meeting on June 9, 2026. The session is scheduled in Mumbai from 1:30 PM to 2:30 PM IST.

04 Jun 2026

companies

Senores Pharma to meet investors

Senores Pharmaceuticals Limited will hold an investor conference in Mumbai on May 25, 2026. The meeting is hosted by Ambit Capital.

20 May 2026

companies

Senores Pharma Eyes 30-40% Revenue Growth in FY27

Senores Pharmaceuticals targets 30-40% revenue growth and ~60% profit growth in FY27, following a strong FY26 with PAT surging 108% to Rs 122 crores.

15 May 2026

companies

Read More

Open Your Free Demat Account

Enter your phone number